- 220
- 34 512
Digital Medicine Society (DiMe)
Приєднався 18 чер 2019
Scaling Digital Health Globally: Navigating National Pathways for Patient Access
Navigating global pathways to scale digital health technologies (DHTs) is complex. DiMe's new resources are designed to help you with actionable insights to understand and compare regulatory environments across Asia Pacific, Europe, and North America. With country-specific guides, step-by-step flowcharts, and supporting resources, you’ll be equipped to streamline your go-to-market strategies and bring your digital health innovations to patients worldwide faster and more efficiently.
Watch our launch event to learn more!
Watch our launch event to learn more!
Переглядів: 12
Відео
Transforming Alzheimer’s Disease and Related Dementia Research: New Core Digital Clinical Measures
Переглядів 7014 годин тому
Alzheimer’s disease and related dementias (collectively referred to as ADRD) have become a public health epidemic. Globally, ADRD affects 47 million people and the expected growth is staggering, with cases expected to double every 20 years. Even with the increased number of ADRD cases, progress in using digital technologies in clinical research has been limited, and there’s been very little wor...
Qualification & Acceptance of Digital Health Technology-Derived Clinical Trial Endpoints
Переглядів 10414 днів тому
Regulatory Pathways for Qualification and Acceptance of Digital Health Technology-Derived Clinical Trial Endpoints: Considerations for Sponsors
Net financial benefits of digital endpoints publication in Clinical and Translational Science
Переглядів 71128 днів тому
Digital measures offer the clinical trials community unparalleled insights into people’s real-life experiences, enhancing our understanding of numerous conditions. So, why haven’t we implemented digital endpoints on a larger scale? Findings from research conducted by DiMe, Tufts Center for the Study of Drug Development, Johnson & Johnson, Roche, Genentech, UCB, Bayer, Takeda, and MindMed, now p...
DiMe Journal Club: Wearable Digital Health Technology
Переглядів 124Місяць тому
There is a growing body of evidence to support the integration of digital health technologies into clinical care, yet several roadblocks must still be addressed to fully realize the potential of DHTs to advance understanding of health and disease. Our work describes several of these challenges, including data ownership, patient trust and empowerment, data standards and interoperability, and ret...
Defining Good Video Series Part 3
Переглядів 54Місяць тому
DiMe CEO, Jennifer Goldsack continues the discussion on the current state of the digital health landscape.
Defining Good Video Series Part 2
Переглядів 832 місяці тому
DiMe CEO, Jennifer Goldsack continues the discussion on the current state of the digital health landscape.
Advancing Equity and Reducing Financial Toxicity in Cancer Care
Переглядів 1892 місяці тому
Patient navigation programming is highly effective in facilitating equitable access to cancer care, reducing financial toxicity, and improving health and quality of life outcomes for cancer patients. However, resource limitations impact the ability of health systems and their partners to scale patient navigation programs to meet comprehensive care needs. Health systems and their partners can le...
Digital Health Software Products are at a Tipping Point - Part 1
Переглядів 2882 місяці тому
DiMe CEO, Jennifer Goldsack weighs in on the current state of the digital health landscape.
What's your Type? Digital Health Technologies has Got Diabetes Covered
Переглядів 934 місяці тому
DiMe and FDA are jointly leading a public meeting to identify the best practices for using Patient-Generated Health Data (“PGHD”) and improve the attendees’ understanding of PGHD implementation during medical device development and clinical studies. Using insights from this meeting, they will develop resources to help key stakeholders implement PGHD throughout the total product life cycle.
Paving the Way to Vision 2030 How to Make the Future of Clinical Research a Reality Today using PGHD
Переглядів 1554 місяці тому
DiMe and FDA are jointly leading a public meeting to identify the best practices for using Patient-Generated Health Data (“PGHD”) and improve the attendees’ understanding of PGHD implementation during medical device development and clinical studies. Using insights from this meeting, they will develop resources to help key stakeholders implement PGHD throughout the total product life cycle.
A View from Washington: Building the Clinical Trials Infrastructure in the US for Healthier Future
Переглядів 754 місяці тому
DiMe and FDA are jointly leading a public meeting to identify the best practices for using Patient-Generated Health Data (“PGHD”) and improve the attendees’ understanding of PGHD implementation during medical device development and clinical studies. Using insights from this meeting, they will develop resources to help key stakeholders implement PGHD throughout the total product life cycle.
Bring the Megaphone, Give it to the Patients First
Переглядів 554 місяці тому
DiMe and FDA are jointly leading a public meeting to identify the best practices for using Patient-Generated Health Data (“PGHD”) and improve the attendees’ understanding of PGHD implementation during medical device development and clinical studies. Using insights from this meeting, they will develop resources to help key stakeholders implement PGHD throughout the total product life cycle.
From Rarity to Clarity: PGHD’s Role in Rare Diseases
Переглядів 1314 місяці тому
DiMe and FDA are jointly leading a public meeting to identify the best practices for using Patient-Generated Health Data (“PGHD”) and improve the attendees’ understanding of PGHD implementation during medical device development and clinical studies. Using insights from this meeting, they will develop resources to help key stakeholders implement PGHD throughout the total product life cycle.
From Traditional to Digital: A Full Spectrum of PGHD Driving Clinical Trial Advancements
Переглядів 1814 місяці тому
DiMe and FDA are jointly leading a public meeting to identify the best practices for using Patient-Generated Health Data (“PGHD”) and improve the attendees’ understanding of PGHD implementation during medical device development and clinical studies. Using insights from this meeting, they will develop resources to help key stakeholders implement PGHD throughout the total product life cycle.
Measuring Health: One that actually matters to (real) patients
Переглядів 1334 місяці тому
Measuring Health: One that actually matters to (real) patients
Turning Up the Volume of Health Monitors: New Modalities of Measuring Health
Переглядів 884 місяці тому
Turning Up the Volume of Health Monitors: New Modalities of Measuring Health
Vision 2030: Advancing Clinical Research with Patient-Generated Health Data
Переглядів 2634 місяці тому
Vision 2030: Advancing Clinical Research with Patient-Generated Health Data
Digital Measurement of Nocturnal Scratch:New Developments
Переглядів 1385 місяців тому
Digital Measurement of Nocturnal Scratch:New Developments
Nocturnal Scratch Webinar Series: Updates From R&D of Algorithms and Tools
Переглядів 4015 місяців тому
Nocturnal Scratch Webinar Series: Updates From R&D of Algorithms and Tools
Nocturnal Scratch Webinar Series: Recent Regulatory Feedback
Переглядів 7 тис.5 місяців тому
Nocturnal Scratch Webinar Series: Recent Regulatory Feedback
How can innovators efficiently construct evidence for their products?
Переглядів 1036 місяців тому
How can innovators efficiently construct evidence for their products?
Advancing Sleep Research: New Core Digital Measures & Resources
Переглядів 3036 місяців тому
Advancing Sleep Research: New Core Digital Measures & Resources
Clinical trial efficiency using data and digital health tech
Переглядів 1407 місяців тому
Clinical trial efficiency using data and digital health tech
Defining the Dimensions of Diversity to Promote Inclusion in the Digital Era of Healthcare
Переглядів 887 місяців тому
Defining the Dimensions of Diversity to Promote Inclusion in the Digital Era of Healthcare
V3+: An extension to the V3 framework
Переглядів 3178 місяців тому
V3 : An extension to the V3 framework
The Promise of Artificial Intelligence and Machine Learning for Improving Clinical Outcomes
Переглядів 2729 місяців тому
The Promise of Artificial Intelligence and Machine Learning for Improving Clinical Outcomes
Making Strides with Digital Measures of Physical Activity: A Digital Strategy for the 6th Vital Sign
Переглядів 2929 місяців тому
Making Strides with Digital Measures of Physical Activity: A Digital Strategy for the 6th Vital Sign
Incorporating Digitally Derived Endpoints within Clinical Development Programs
Переглядів 15010 місяців тому
Incorporating Digitally Derived Endpoints within Clinical Development Programs
😢
Не понимаю иностранный.Необходимы хотя бы субтитры
Я не пойму
Dear Sir/Ma'am, I will provide you Paid Guest Posting service. Guest post is the best backlinks nowadays, it is popular with everyone. Premium sites get real traffic and guest post backlink is the right way to rank your website fast. I can rank your website fast with guest posts service.
Thank you for including me in the comversation. Looking forward to seeing what 2030 brings. 💜
Thanks for wonderful conversation on vital issues concerning digital health information technology capabilities to measure the meaningful interventions grounded evidences recorded at surface wide sensing, signalling and smoothening predictive prognostic, diagnostic and analytic capacity for detecting rate of change in human bodily functional structural principal muscular skeletal dynamics associated at rest / movement bioenergetics anatomy of spiritual flow state chained phase transitions modes of operations.
Have you been thinking to adding column if the data for a particular experiment is open access? Anonymized of course.
This was an excellent discussion, thank you! Where can we learn more about the upcoming AMA report due 9/11/23? I wasn’t able to find it on their website.
P r o m o S M
cannot get sound on, any hints?
6 presenters and only 1 like .interesting
Great conversation and input on the importance of keeping the integrated perspective of patients, pharma and payors when adopting digital clinical endpoints - excellent resources to reference
I love the video. Become an online boss = P R O M O S M!!
Thank you for uploading the video on UA-cam. This discussion is critical to the field!
Basically my theory on that says minute if you're stating that the legal consequences of subsidizing drugs and the environment that are basically the habitat to the community maybe arrested in the friendly as said for and if it's possible to do so that we can actually transform the downtown area until Midtown up. That way everybody will be legal
I means you rushed them many people get evaluated as being homeless and institutionalize in the State Penitentiary due to the fact of illegal infringement cases
That means they can't live there